TSE:NVLN Novelion Therapeutics Inc, (NVLN) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free NVLN Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$13.30▼C$13.3052-Week Range N/AVolume3,639 shsAverage Volume3,220 shsMarket CapitalizationC$251.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Novelion Therapeutics Inc, alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Novelion Therapeutics Inc,Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.Read More Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide NVLN Stock News HeadlinesApril 21, 2024 | finance.yahoo.comVoyager Therapeutics, Inc. (VYGR)April 18, 2024 | investing.comVivos Therapeutics Inc (VVOS)April 25, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.March 24, 2024 | morningstar.comCentury Therapeutics Inc IPSCFebruary 14, 2024 | wsj.comCymaBay Therapeutics Inc.February 6, 2024 | investing.comAclaris Therapeutics Inc (ACRS)January 3, 2024 | investing.comHighTide Therapeutics Inc (2511)December 30, 2023 | investing.comIntensity Therapeutics Inc (INTS)April 25, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.December 17, 2023 | morningstar.comLeap Therapeutics Inc LPTXNovember 14, 2023 | morningstar.comAileron Therapeutics Inc ALRNNovember 11, 2023 | morningstar.comAtossa Therapeutics Inc ATOSNovember 1, 2023 | morningstar.comBeam Therapeutics Inc BEAMNovember 1, 2023 | morningstar.comAprea Therapeutics Inc APRENovember 1, 2023 | morningstar.comCelldex Therapeutics Inc CLDXOctober 31, 2023 | morningstar.comCARISMA Therapeutics Inc CARMSeptember 29, 2023 | finance.yahoo.comIs Viking Therapeutics, Inc. a Buy?August 26, 2023 | seekingalpha.comIMUN Immune Therapeutics, Inc.August 24, 2023 | seekingalpha.comELVN Enliven Therapeutics, Inc.May 10, 2023 | morningstar.comSigilon Therapeutics Inc Ordinary SharesApril 25, 2023 | finance.yahoo.comSarepta Therapeutics, Inc. (SRPT)April 20, 2023 | morningstar.comNurix Therapeutics Inc Ordinary SharesApril 20, 2023 | seekingalpha.comZVSA ZyVersa Therapeutics, Inc.March 26, 2023 | finanznachrichten.deDefence Therapeutics Inc.: Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 MillionFebruary 26, 2023 | benzinga.comWindtree Therapeutics Stock (NASDAQ:WINT), Quotes and News SummaryJanuary 28, 2023 | seekingalpha.comFDMT 4D Molecular Therapeutics, Inc.January 27, 2023 | seekingalpha.comAVTE Aerovate Therapeutics, Inc.See More Headlines Receive NVLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novelion Therapeutics Inc, and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolTSE:NVLN Previous SymbolTSE:QLT CUSIPN/A CIKN/A Webwww.novelion.com Phone+1-604-7077000FaxN/AEmployees109Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares18,932,000Free FloatN/AMarket CapC$251.80 million OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key CompetitorsImvescor Restaurant GroupTSE:IRGRedknee SolutionsTSE:RKNHalogen SoftwareTSE:HGNTIO NetworksCVE:TNCAMI.TOTSE:AMIView All Competitors NVLN Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Novelion Therapeutics Inc, own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novelion Therapeutics Inc, investors own include Alnylam Pharmaceuticals (ALNY), NXP Semiconductors (NXPI), Whole Foods Market (WFM), InvenSense (INVN), OPKO Health (OPK), Vitamin Shoppe (VSI), Aurora Cannabis (ACB), ABGBY (ABGBY), Gilead Sciences (GILD) and 3D Systems (DDD). How do I buy shares of Novelion Therapeutics Inc,? Shares of NVLN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NVLN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novelion Therapeutics Inc, Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
